相关实验视频
Updated: Jun 10, 2025

06:10
An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis
Published on: August 6, 2020
5.6K
Bim表达影响胆管内皮细胞特征及其对治疗干预的反应
Nader Sheibani1,2,3, Yong-Seok Song1,3, Mitra Farnoodian1,3
1Department of Ophthalmology and Visual Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI 53705, USA.
International journal of molecular sciences
|October 16, 2024
概括
胆道内皮细胞中的Bim缺乏促进了新血管化,并降低了抗VEGF治疗的有效性. 在Bim缺陷个体中,胆道新血管化 (CNV) 的替代治疗可能是可行的.
科学领域:
- 眼科医生 眼科 眼科
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
背景情况:
- 胆道新血管化 (CNV) 在老年人群中导致视力丧失.
- 冠状动脉瘤涉及异常的血管生长和冠状内皮细胞 (ChECs) 中不适当的细胞死亡 (细胞亡).
- 比姆是一种亲细胞亡的蛋白质,对调节ChEC细胞亡至关重要.
研究的目的:
- 调查Bim在胆道血管完整性和新血管化中的作用.
- 确定Bim缺乏如何影响ChEC行为和对抗VEGF治疗的反应.
主要方法:
- 从野生型和Bim-缺乏 (Bim-/-) 的小鼠中分离出来的ChEC.
- 评估了ChEC扩散,毛细血管形态发生和基因表达.
- 利用老鼠激光光凝模型诱导和治疗体内CNV.
- 评估了抗VEGF治疗和其他潜在治疗方法的疗效.
主要成果:
- Bim-/- ChECs表现出增加的VEGF,骨质素,兰特斯/Ccl5和IL6表达.
- 双缺乏增强了ChEC的扩散和毛细血管形态发生.
- 抗VEGF治疗在破坏Bim-/- ChECs中的毛细血管形态发生和在体内减轻CNV方面效果不佳.
- 兰醇,抗CTGF和ABT898在减轻Bim缺乏小鼠中CNV的疗效不同.
结论:
- 在ChEC中Bim表达影响了针对CNV内在死亡途径的疗法的有效性.
- 双缺乏症可能需要替代性治疗策略来治疗中枢神经病毒.
- 了解Bim的作用对于开发有效的CNV疗法至关重要.
相关概念视频
iPS Cell Differentiation
2.6K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.6K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K

